Urologists generally reserve this treatment for individuals classified as having intermediate or high risk of recurrence or progression. Understanding How BCG Works at the Cellular Level Unlike chemotherapy, which circulates throughout the entire body, intravesical therapy confines the treatment to the urinary tract.
Long Term BCG Outcomes and Survival Rates for Bladder Cancer
When the BCG solution is retained in the bladder for a prescribed period, usually one to two hours, the bacteria attach to the bladder wall. Patients who have failed prior intravesical therapies or who have tumors that are resistant to other treatments may also be considered for BCG therapy, provided they can tolerate the potential side effects.
Common reactions include urinary frequency, urgency, and dysuria, which resemble a persistent bladder infection. This maintenance phase can extend for one to three years, involving instillations at longer intervals, such as once a week for three weeks every three months.
Long Term BCG Outcomes and Survival Rates for Bladder Cancer
Following this initial phase, maintenance therapy is frequently recommended to sustain the immune response. This organ-sparing advantage is a significant reason why the treatment remains a preferred option in the oncology community.
More About Intravesical therapy bcg
Looking at Intravesical therapy bcg from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Intravesical therapy bcg can make the topic easier to follow by connecting earlier points with a few simple takeaways.
